Home > PS Ratio > NGL FINECHEM

NGL FINECHEM
PS (Price/Sales) Ratio

The Current P/S Ratio of NGL FINECHEM is 4.91.

Share Price ₹2,478.5Apr 23,2024
Market Cap ₹1,536.7 Cr
Sales-TTM₹313.1 CrTTM-Consolidated Results
Price/Sales4.91xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results
NGL FINECHEM is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of NGL FINECHEM

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of NGL FINECHEM is calculated as :

Current Market Cap [ ₹1,536.7 Cr] as on Apr 23,2024

(/) Sales [ ₹313.1 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 4.91x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for NGL FINECHEM , the investors are currently willing to pay '4.91 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of NGL FINECHEM !

The chart below summarizes the trend in P/S Ratio of NGL FINECHEM over the last five years.

Historical PS (Price/Sales) ratio chart of NGL FINECHEM


PS Ratio Performance Analysis for NGL FINECHEM

- NGL FINECHEM 's latest p/e ratio is 4.91x.

- NGL FINECHEM 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 2.61x.

- NGL FINECHEM 's operated at median p/e ratio of 2.66x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, NGL FINECHEM 's p/e ratio peaked in Mar2022 at 3.81x.

- NGL FINECHEM 's p/e ratio hit its five-year low in Mar2020 of 1.03x.


How does NGL FINECHEM 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
NGL FINECHEM 313.14.911,536.7
SUN PHARMACEUTICAL INDUSTRIES LTD47,444.67.50356,001.0
CIPLA LTD25,350.24.29108,813.0
DR REDDYS LABORATORIES LTD27,212.53.6599,325.3
ZYDUS LIFESCIENCES LTD19,024.25.0896,553.2
DIVIS LABORATORIES LTD7,492.813.36100,075.0
MANKIND PHARMA LTD9,946.39.6495,896.9
TORRENT PHARMACEUTICALS LTD10,474.08.5289,224.4
LUPIN LTD19,480.13.7072,033.6
AUROBINDO PHARMA LTD27,894.72.3064,043.1
ABBOTT INDIA LTD5,753.49.5154,704.8

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs NGL FINECHEM 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.30x
Max industry PS 13.36x
Median industry PS 5.08x
Average industry PS 6.59x



You may also like the below Video Courses